Advanced Search

Cost Analysis of a Transition Care Bundle Compared with Usual Care for COPD Patients Being Discharged from Hospital: Evaluation of a Randomized Controlled Trial

Appropriate management of chronic obstructive pulmonary disease (COPD) patients following acute exacerbations can reduce the risk of future exacerbations, improve health status, and lower care costs. While a transition care bundle (TCB) was associated with lower readmissions to hospitals than usual care (UC), it remains unclear whether the TCB was associated with cost savings. The aim of this study was to evaluate how this TCB was associated with future Emergency Department (ED)/outpatient visits, hospital readmissions, and costs in Alberta, Canada.

Using data from the multicentre cohort study with a nested randomized controlled trial, this study evaluated the effectiveness of a chronic obstructive pulmonary disease (COPD) transition bundle on hospital readmissions and ED revisits compared to usual care. Results showed that the transition bundle led to shorter hospital stays and lower costs, making it a cost-saving intervention for patients with acute COPD exacerbations. Decision modelling also indicated that the transition bundle was more economically attractive than its comparator.

Publication Type: Journal Articles

Year of Publication: 2023

Topics: COPD, Health Economics / Healthcare Costs

Authors: Charles Yan, Jeff Round, Ilke Akpinar, Chantal Atwood, Lesly Deuchar, Mohit Bhutani, Richard Leigh, Michael Stickland

Journal Title: PharmacoEconomics (Open)